Ferroptosis functions remarkably in T cell-driven adverse outcomes of cancer cells, and HnRNPL inhibits Jurkat T cell-mediated Castration-Resistant Prostate Cancer (CRPC) cell ferroptosis through the YY1/PD-L1 axis, partially promoting cancer immune escape. This evidence concerns the gene YY1 and cancer.